Skip to main content
. 2009 Apr;155(Pt 4):1226–1240. doi: 10.1099/mic.0.025759-0

Table 1.

Oligonucleotides used in this study

Name Sequence Application*
CA_HMG_F+START ATGTTGAGATCATTTGTAACATC (23-mer) 1, 3
CA_HMG_R AAAGTCATCCTCCACTTTGTAG (22-mer) 1, 4
CA_HMG_R+STOP TCAAAAGTCATCCTCCACTTTG (22-mer) 1
5BamORF ATGGATCCATGTTGAGATCATTTGTAACA (29-mer) 1, 2
REsp3ORF ATCGTCTCTACATAAAGTCATCCTCCACTTTGTA (34-mer) 1
5GFPEsp3 ATCGTCTCAATGTCTAAAGGTGAAGAATTA (30-mer) 1, 3
3PstGFP ATCTGCAGTTATTTGTACAATTCATCCAT (29-mer) 1
3PstORF ATCTGCAGGTCAGTAATTCACTTTTCCGG (29-mer) 1, 3, 4
R3OUT ATGAGCTCTATTTCTCGAATCAGTTGATT (29-mer) 1, 2, 3
D3orf ATTGCGGCCGCCTCAATCAACTAAAAGAGGTC (32-mer) 1
R5orf ATACTCGAGAGATGAACAACTAAAATTGAC (30-mer) 1
D5OUT ATGGGCCCACTAATATTTTACCTGCAGGG (29-mer) 1
pMET ATGAAAAGACAAGAGAGC (18-mer) 4
GFP AGATGGTGATGTTAATGG (18-mer) 4
pGEX5 GGCAAGCCACGTTTGGTG (18-mer) 4
pGEX3 GGAGCTGCATGTGTCAGAGG (20-mer) 4
5ORFterm ATCTGCAGAGAACTCAATCAACTAAAA (27-mer) 3
D3OUT ATTGCGGCCGCCGATGGATGGATGACGAGAAC (32-mer) 2
IMH3OUT AGAGGTATGGGTTCCATCGAT (21-mer) 3
3PstKO ATCTGCAGTGCCTTCTCTTCCTCGGGGAA (29-mer) 2
CaAbf2Rev TCAATAGTCAAATAAAGTAGC (21-mer) 3
CaUra3in3 TAATTGGCCAGTCTTTTTCAAATAAGC (27-mer) 2
CamtHMG1in5 GTGGTACCATCACCGACTTCA (21-mer) 3
CamtHMG1in3 ATCCGCAGCAACCGTCAATT (20-mer) 3
MPAout3 AGATCCACTAGTTCTAGAGCGGCC (24-mer) 3
MPAout5 CTAGAAAGTATAGGAACTTCCTCGAG (26-mer) 3
D5R5in ATATTCTCCATTATACTTTGTATTGG (26-mer) 2
D3R3in AACTATGGTCAAAAGGGTCTAAAAA (25-mer) 2
CanEco31 ACGTGGTCTCATGGAATTAACACCCACACAG (31-mer) 2
Can3CBam GCGGATCCTAAATTAGTCGACTAGT (25-mer) 2
5RTcaAct1 TGTCTTTGTACTCTTCTGGTAGAAC (25-mer) 5
3RtcaAct1 CTAGTAGTGAAACTGTAACCACGTT (25-mer) 5
5RTcaGCF1 CAAAAGCTATTTTACTCCTAAACCA (25-mer) 5
3RTcaGCF1 ATCTTCTTTACTGATTTGGTATTGC (25-mer) 5
5RTcaNAD2 TTCAAAATGGGATTAGCACCTT (22-mer) 5
3RTcaNAD2 TGTATATGCTGCCACGGCTA (20-mer) 5

*1, PCR amplification for cloning; 2, PCR amplification to prepare probe for Southern blot hybridization; 3, PCR verification; 4, sequencing; 5, qRT-PCR.